Immunovia AB Market Cap

Immunovia AB has a market cap or net worth of 136.22 million as of April 24, 2026. Its market cap has increased by 82.81% in one year.

Market Cap

136.22M

Enterprise Value

59.61M

Revenue

685.00K

Ranking

n/a

PE Ratio

n/a

Stock Price

0.20

Market Cap Chart

Since December 1, 2015, Immunovia AB's market cap has decreased from 424.45M to 136.22M, a decrease of -67.91%. That is a compound annual growth rate of -10.35%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2026	136.22M	-10.79%
Dec 30, 2025	152.70M	64.79%
Dec 30, 2024	92.66M	15.47%
Dec 29, 2023	80.25M	-86.52%
Dec 30, 2022	595.21M	-64.93%
Dec 30, 2021	1.70B	-37.08%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Dec 30, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Swedish Orphan Biovitrum AB	138.47B
Getinge AB	53.38B
Sectra AB	51.79B
Camurus AB	33.49B
Physitrack	147.65M
Scandinavian Real Heart AB (Publ)	144.46M
Clinical Laserthermia Systems AB	143.38M
Alligator Bioscience AB	138.50M

Market Cap Rankings